Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | ADH1B | P00325 | 1/20 | 0.39 |
| ▸ | ADH1C | P00326 | 1/20 | 0.39 |
| ▸ | ADH1A | P07327 | 1/20 | 0.39 |
| ▸ | ADH4 | P08319 | 1/20 | 0.39 |
| ▸ | ADH7 | P40394 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10585389 | 1.00 | EPHX1 (0.50) | EPHX1HPGDKMT2AEPHX2ALOX5 | |
| SCHEMBL10586821 | 1.00 | EPHX1 (0.50) | EPHX1HPGDKMT2AEPHX2ALOX5 | |
| SCHEMBL10585614 | 0.97 | — | — | |
| SCHEMBL10402883 | 0.92 | — | — | |
| SCHEMBL9442144 | 0.86 | — | — | |
| SCHEMBL7945281 | 0.78 | EPHX1 (0.54) | EPHX1HPGDKMT2AEPHX2ALOX5 | |
| SCHEMBL1148328 | 0.78 | EPHX1 (0.54) | EPHX1HPGDKMT2AEPHX2ALOX5 | |
| SCHEMBL7085369 | 0.78 | EPHX1 (0.54) | EPHX1HPGDKMT2AEPHX2ALOX5 | |
| SCHEMBL502374 | 0.77 | EPHX1 (0.48) | EPHX1HPGDKMT2AEPHX2ALOX5 | |
| SCHEMBL10402813 | 0.76 | EPHX1 (0.52) | EPHX1HPGDKMT2AEPHX2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3962917-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | Momentive Performance Materials Inc. (US) | 2022-03-09 | — | — | EP | claimed |
| US-10919920-B2 | Method for the manufacture of alkoxysilyl-containing thiocarboxylic acid esters | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2021-02-16 | — | — | US | claimed |
| WO-2020223068-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2020-11-05 | — | — | WO | claimed |
| US-20200347084-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2020-11-05 | — | — | US | claimed |
| CN-115974758-A | Carboxymethyl ketone compound and preparation method thereof | 生物岛实验室 | 2023-04-18 | — | — | CN | disclosed |
| EP-3962917-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | Momentive Performance Materials Inc. (US) | 2022-03-09 | — | — | EP | disclosed |
| US-10919920-B2 | Method for the manufacture of alkoxysilyl-containing thiocarboxylic acid esters | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2021-02-16 | — | — | US | disclosed |
| WO-2020223068-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2020-11-05 | — | — | WO | disclosed |
| US-20200347084-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2020-11-05 | — | — | US | disclosed |
| EP-2046710-A1 | PROCESS FOR ALKALINE HYDROLYSIS OF CARBOXYLIC ACID DERIVATIVES TO CARBOXYLIC ACIDS | Krause-Röhm-Systeme AG (DE) | 2009-04-15 | — | — | EP | disclosed |
| WO-2008012118-A1 | PROCESS FOR ALKALINE HYDROLYSIS OF CARBOXYLIC ACID DERIVATIVES TO CARBOXYLIC ACIDS | KRAUSE-RÖHM-SYSTEME AG (DE) | 2008-01-31 | — | — | WO | disclosed |
| US-4952690-A | 6-substituted thia-aza compounds | CIBA-GEIGY CORPORATION (US) | 1990-08-28 | — | — | US | disclosed |
| EP-0319316-A2 | Griseolic acid monoesters, their preparation and use | SANKYO COMPANY LIMITED (JP) | 1989-06-07 | — | — | EP | disclosed |
| US-4692442-A | ANTIBIOTICS | CIBA-GEIGY CORPORATION (US) | 1987-09-08 | — | — | US | disclosed |
| EP-0042026-B1 | 3,4-DISUBSTITUTED AZETIDIN-2-ON COMPOUNDS AND PROCESS FOR THEIR PREPARATION | CIBA-GEIGY AG (CH) | 1986-01-08 | — | — | EP | disclosed |
| EP-0003960-B1 | 6-SUBSTITUTED THIA-AZA-COMPOUNDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | CIBA-GEIGY AG (CH) | 1983-06-29 | — | — | EP | disclosed |
| EP-0042026-A1 | 3,4-Disubstituted azetidin-2-on compounds and process for their preparation | CIBA-GEIGY AG (CH) | 1981-12-23 | — | — | EP | disclosed |
| EP-0003960-A1 | 6-Substituted thia-aza-compounds, their preparation and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1979-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919920-B2 | Method for the manufacture of alkoxysilyl-containing thiocarboxylic acid esters | TST, MPST, APEH | EPHX1 2754/4885HPGD 1632/4885KMT2A 2249/4885 |
| US-20200347084-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | TST, MPST, APEH | EPHX1 2754/4885HPGD 1632/4885KMT2A 2249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.